In the VALOR trial, brepocitinib 30 mg demonstrated clinically meaningful and statistically significant improvement compared ...

Each Sunday we feature a highlight reel of various articles posted on our website that week.

Expensive, newer therapies and a lack of pediatric data are roadblocks to advancing treatment for pediatric atopic dermatitis ...

Determining a biologic's duration of use to treat pediatric atopic dermatitis has several factors, according to Lawrence ...

There are some 40 interleukins that play a wide variety of roles in inflammation and the body’s immune response, some of them hitting the accelerator and others tapping the brakes. When it comes to ...

Mona Shahriari, M.D., dermatologist at Central Connecticut Dermatology and an associate clinical professor at Yale School of Medicine discusses the highlights of her session called ‘Seeing Clearly: A ...

Nearly 1 in 10 U.S. adults report having physician-diagnosed chronic head eczema, according to findings from a ...

Eichenfield said that depending on severity, atopic dermatitis treatment is begun right away in these younger patients ...

The 2025 Fall Clinical Dermatology Conference will be held in Las Vegas, Nevada, from Oct. 23 to 26. Eichenfield will present ...

The use of interleukin (IL)-23 inhibitors plays an important role in treating patients with psoriasis, as well as in treating ...

Unlike existing treatments that block individual cytokines such as IL-4, IL-13 or IL-31, therapies targeting the OX40 pathway ...

Shawn Kwatra, M.D., Joseph W. Burnett endowed professor and chair of dermatology at the University of Maryland School of ...